Zobrazeno 1 - 5
of 5
pro vyhledávání: '"L Raich Montiu"'
Autor:
M. García Argelaguet, MQ Gorgas Torner, L Borràs Trias, L Raich Montiu, C. Pontes García, M De Castro Julve
Publikováno v:
European Journal of Hospital Pharmacy. 22:A108.2-A109
Background It has been repeatedly reported that up to 7% of patients have serious adverse drug reactions (ADR) during hospital admissions. Hospital-based pharmacovigilance aims to detect previously unknown serious ADRs arising during differential dia
Autor:
MQ Gorgas Torner, L Ortiz Ruiz, A Estefanell Tejero, E Oliver Ferrer, L Borràs Trias, C. Pontes García, N Rudi Sola, L Raich Montiu, M De Castro Julve
Publikováno v:
European Journal of Hospital Pharmacy. 22:A109.1-A109
Background Tenofovir/emtricitabine/rilpivirine (TDF/FTC/RPV) is a recently-marketed fixed-dose combination of antiretrovirals with which there is little clinical experience as yet. Purpose To describe our clinical experience with TDF/FTC/RPV, in term
Autor:
Milagros García-Peláez, MQ Gorgas Torner, M. Cabré Serres, L Borràs Trias, M Gómez-Valent, L Raich Montiu, ML Iglesias Lepine, M De Castro Julve, M Payés Peich
Publikováno v:
European Journal of Hospital Pharmacy. 21:A145.2-A145
Background Clinical safety is an essential component of health care quality. The EVADUR study showed that 12% of patients who were in the emergency department (ED) had adverse events (AE). 70% of them were considered avoidable. Purpose To describe ph
Autor:
L Raich Montiu, MQ Gorgas Torner, C. Pontes García, M.C. Frías López, M. Cabré Serres, A.B. Montero Leno, M Gómez-Valent
Publikováno v:
European Journal of Hospital Pharmacy. 19:179.2-179
Background Ipilimumab has been approved to treat patients with late-stage melanoma and it has been associated with potentially fatal immunological adverse effects due to T cell activation and proliferation. Purpose To analyse the causality of a fatal
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.